By identifying the proper product category, we worked with an international company to correctly reposition its drug-device combination product for FDA approval and drive market penetration.
Case Studies Articles and Insights
When a biotech company could not afford the time and expense to conduct intended studies, we stepped in and quickly and creatively turned things around with the FDA.
After a biotech company received paper NDA approval for their drug, Camargo contributed to successful commercialization, planning and executing Phase 4 post-marketing requirements with a short timeline.
With strategic submission support, a biotech company gained approval for an improved delivery technology of an already-approved drug, setting the potential to become a new “gold standard” treatment in oncology.